Metraipolis › archive › dc_bc41d397fc21

Impact and effectiveness of Australia's 2025 hybrid RSV immunisation program: results from the PAEDS-FluCAN Network — Europe PMC PMID:42569662

Source: Europe PMC (en)
Original: https://europepmc.org/article/MED/42569662
DOI: 10.1016/j.lanwpc.2026.101938
License (as archived): solo-consultazione
Archived: 2026-10-17T11:27:44.885Z
SHA-256 of the archived text: ccde683e66692c3e2aef85219aebd603050b752961359ed2e338590aad9923f1
Stable URL of this page: https://metraipolis.com/documento/dc_bc41d397fc21

How to cite

Impact and effectiveness of Australia's 2025 hybrid RSV immunisation program: results from the PAEDS-FluCAN Network — Europe PMC PMID:42569662 — Europe PMC (en), https://europepmc.org/article/MED/42569662 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_bc41d397fc21 (Metraipolis archive dc_bc41d397fc21, sha256 ccde683e66692c3e2aef85219aebd603050b752961359ed2e338590aad9923f1)

BibTeX

@misc{dcbc41d397fc21,
  title = {Impact and effectiveness of Australia's 2025 hybrid RSV immunisation program: results from the PAEDS-FluCAN Network — Europe PMC PMID:42569662},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42569662},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_bc41d397fc21; sha256 ccde683e66692c3e2aef85219aebd603050b752961359ed2e338590aad9923f1},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42569662. Agents can read the archived copy with the MCP tool read_document.